Wednesday, May 17, 2017

BRIEF-Eiger announces results of ubenimex and leukotriene b4 (LTB4) modulation in experimental lymphedema

* Eiger announces results demonstrating benefit of ubenimex and leukotriene B4 (LTB4) modulation in experimental lymphedema Source text for Eikon: Further company coverage:

by reutersCOMPANYNEWS via Endless Supplies .Biz - News
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)